Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet J P, Couvreur P
Laboratoire de Pharmacie galénique et Biopharmacie, URA CNRS 1218, Faculté de Pharmacie, Chatenay-Malabry, France.
Cancer Chemother Pharmacol. 1990;26(2):122-6. doi: 10.1007/BF02897257.
In our previous studies, doxorubicin-loaded polyisohexylcyanoacrylate nanoparticles have been proven to increase dramatically the antitumoral activity of the cytotoxic agent in metastasis-bearing mice. The experimental model consisted of metastases induced by i.v. inoculation of reticulosarcoma M 5076 cell suspension to C57BL/6 mice. The improved efficacy of the drug was noted in terms of either metastasis count or survival. Therefore, tissue-distribution studies of this drug delivery system within the metastatic liver after i.v. administration were undertaken to gain more insight into the mechanism of action. Doxorubicin measurements in healthy hepatic or neoplastic tissue were carried out together with histological examinations using transmission electron microscopy. These results demonstrated the hepatic tissue to be an efficient reservoir of the drug when it was injected associated with nanoparticles. Accumulation of biodegradable nanoparticles with associated doxorubicin in Kupffer cells created a gradient of drug concentration for a massive and prolonged diffusion of the free drug towards the neoplastic tissue.
在我们之前的研究中,已证实载有多柔比星的聚异己基氰基丙烯酸酯纳米颗粒可显著提高细胞毒性药物对荷瘤小鼠的抗肿瘤活性。实验模型由通过静脉注射网状肉瘤M 5076细胞悬液诱导C57BL/6小鼠发生转移组成。在转移灶数量或生存期方面均观察到该药物疗效得到改善。因此,开展了静脉给药后该药物递送系统在转移性肝脏内的组织分布研究,以更深入了解其作用机制。使用透射电子显微镜进行组织学检查的同时,对健康肝脏组织或肿瘤组织中的多柔比星进行了测定。这些结果表明,当药物与纳米颗粒结合注射时,肝组织是该药物的有效储存库。可生物降解的纳米颗粒与结合的多柔比星在库普弗细胞中的蓄积形成了药物浓度梯度,使游离药物能够大量且持续地向肿瘤组织扩散。